Clinical Trial Update: hUC Mesenchymal Stem Cells (19#iSCLife®-UT) Therapy for Patients With Thin Endometrial Infertility [Phase 1]

View source ↗

Summary

Phase 1 study evaluating hUC Mesenchymal Stem Cells (19#iSCLife®-UT) therapy for female infertility associated with thin endometrium; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• hUC Mesenchymal Stem Cells (19#iSCLife®-UT) Therapy

Snippet

Sponsor: Sclnow Biotechnology Co., Ltd. | Conditions: Infertility, Female | Phase 1 | Status: COMPLETED